Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Kip518 who wrote (688)	11/11/1997 10:04:00 PM
From: DrJerry	Read Replies (2) \| Respond to of 1605

ABC news is scheduled to have a blurb on the 11pm new tonight! The report on NBC was very favorable. Reliable sources say that Vaso president was interviewed by the Wall Street Journal and that USA Today was also inter- viewing Vaso officials. It seems then that the PR boys have been doing their work and that Vaso understands that not only is efficacy crucial but that selling the technology is needed to make the company fly. My view is that the indications for EECP will be greatly expanded in the near future (renal disease etc.) and that the demand for units will increase. I further see miniaturization which will expand the market. Insurers will be forced to have an across the board policy for this therapy (likely a "global fee") as demand is increased especially by the patient population. A company has been formed in NJ to deal with processing claims from EECP providers and they are currently claiming an 80% success rate in getting reimbursement. If % return is your investment goal then take your profits now- if long term return is your goal then hop on the train and enjoy the ride!!!!!!